Literature DB >> 26392134

Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw.

Ishrat Rahim1, Stephen Salt2, Manolis Heliotis3.   

Abstract

We describe a case of extensive osteonecrosis of the mandible after a dental extraction in a 71-year-old woman who was taking alendronic acid (Fosamax(®), Merck) for osteoporosis. Bone damaged by bisphosphonate-related osteonecrosis of the jaw (BRONJ), also now known as medication-related osteonecrosis of the jaw (MRONJ), can be regenerated and filled with endosseous implants using non-vascularised autologous grafts.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  BMPs; BRONJ; Bisphosphonates; Bone morphogenic proteins; Endosseous implants; MRONJ; Mandibular reconstruction

Mesh：

Substances：

Year:  2015        PMID： 26392134     DOI： 10.1016/j.bjoms.2015.08.006

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


  8 in total

Review 1.  Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering.

Authors:  Maria Giovanna Rizzo; Nicoletta Palermo; Ugo D'Amora; Salvatore Oddo; Salvatore Pietro Paolo Guglielmino; Sabrina Conoci; Marta Anna Szychlinska; Giovanna Calabrese
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

2.  The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.

Authors:  Olga Di Fede; Federica Canepa; Vera Panzarella; Rodolfo Mauceri; Carmine Del Gaizo; Alberto Bedogni; Vittorio Fusco; Pietro Tozzo; Giuseppe Pizzo; Giuseppina Campisi; Antonio Galvano
Journal:  Int J Environ Res Public Health       Date:  2021-08-10       Impact factor: 3.390

3.  The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report.

Authors:  Maria Del Pilar Rodríguez-Sánchez; Cristian Statkievicz; João Martins de Mello-Neto; Luan Felipe Toro; Ana Paula Farnezzi Bassi; Valdir Gouveia Garcia; Letícia Helena Theodoro; Edilson Ervolino
Journal:  J Lasers Med Sci       Date:  2020-01-18

4.  Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate.

Authors:  Valesca Sander Koth; Fernanda Gonçalves Salum; Maria Antonia Zancanaro de Figueiredo; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2020-09-23       Impact factor: 3.573

5.  Segmental Mandibular Reconstruction Using Tissue Engineering Strategies: A Systematic Review of Individual Patient Data.

Authors:  Vinay V Kumar; Elke Rometsch; Andreas Thor; Eppo Wolvius; Anahí Hurtado-Chong
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-04-08

6.  Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.

Authors:  Chunhui Wang; Huimei Zang; Dongsheng Zhou
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

7.  Role of rhBMP-7, Fibronectin, And Type I Collagen in Dental Implant Osseointegration Process: An Initial Pilot Study on Minipig Animals.

Authors:  Gianmario Schierano; Rosa Angela Canuto; Mitzy Mauthe von Degerfeld; Roberto Navone; Bruno Peirone; Giulio Preti; Giuliana Muzio
Journal:  Materials (Basel)       Date:  2021-04-24       Impact factor: 3.623

8.  Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases.

Authors:  Mu-Seong Kim; Kyung-Jin Kim; Bok-Joo Kim; Chul-Hoon Kim; Jung-Han Kim
Journal:  Int J Surg Case Rep       Date:  2019-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.